F. Ann Millner Sells 12,500 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI) Director F. Ann Millner sold 12,500 shares of the company’s stock in a transaction that occurred on Friday, November 15th. The stock was sold at an average price of $101.55, for a total value of $1,269,375.00. Following the transaction, the director now owns 32,391 shares in the company, valued at $3,289,306.05. This trade represents a 27.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Merit Medical Systems Price Performance

Shares of Merit Medical Systems stock opened at $104.08 on Thursday. The stock’s 50-day simple moving average is $98.09 and its 200-day simple moving average is $90.46. Merit Medical Systems, Inc. has a 52 week low of $65.46 and a 52 week high of $105.46. The company has a market capitalization of $6.07 billion, a price-to-earnings ratio of 51.02, a PEG ratio of 2.53 and a beta of 0.89. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Wednesday, October 30th. The medical instruments supplier reported $0.86 EPS for the quarter, beating the consensus estimate of $0.80 by $0.06. Merit Medical Systems had a return on equity of 15.61% and a net margin of 9.05%. The business had revenue of $339.85 million for the quarter, compared to the consensus estimate of $334.60 million. During the same period in the previous year, the business earned $0.75 earnings per share. The business’s revenue was up 7.8% on a year-over-year basis. As a group, analysts expect that Merit Medical Systems, Inc. will post 3.36 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on MMSI shares. Needham & Company LLC restated a “buy” rating and issued a $109.00 price target on shares of Merit Medical Systems in a research note on Thursday, October 31st. Piper Sandler restated an “overweight” rating and issued a $110.00 price target (up previously from $100.00) on shares of Merit Medical Systems in a research note on Monday, September 9th. StockNews.com downgraded Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Sunday, November 3rd. Bank of America increased their target price on Merit Medical Systems from $92.00 to $103.00 and gave the company a “neutral” rating in a research note on Monday, September 16th. Finally, Wells Fargo & Company increased their target price on Merit Medical Systems from $85.00 to $103.00 and gave the company an “equal weight” rating in a research note on Monday, September 16th. Three analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Merit Medical Systems presently has a consensus rating of “Moderate Buy” and a consensus target price of $103.36.

Institutional Investors Weigh In On Merit Medical Systems

Large investors have recently made changes to their positions in the company. UniSuper Management Pty Ltd bought a new stake in shares of Merit Medical Systems in the first quarter worth about $1,083,000. State Board of Administration of Florida Retirement System grew its stake in shares of Merit Medical Systems by 36.4% during the first quarter. State Board of Administration of Florida Retirement System now owns 22,144 shares of the medical instruments supplier’s stock valued at $1,638,000 after buying an additional 5,915 shares during the last quarter. Van ECK Associates Corp bought a new position in shares of Merit Medical Systems during the third quarter valued at approximately $718,000. Lazard Asset Management LLC boosted its holdings in shares of Merit Medical Systems by 1,147.3% in the first quarter. Lazard Asset Management LLC now owns 7,858 shares of the medical instruments supplier’s stock valued at $594,000 after purchasing an additional 7,228 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of Merit Medical Systems by 2.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 838,843 shares of the medical instruments supplier’s stock valued at $63,543,000 after purchasing an additional 22,077 shares during the period. 99.66% of the stock is owned by institutional investors.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.